Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Ban, Andrea ^a   Ismail, Aniza ^a   Harun, Roslan ^a   Abdul Rahman, Azahirafairud ^a   Sulung, Saperi ^a   Syed Mohamed, Aljunid ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b United Nations University International Institute of Global Health (UNU IIGH)   (Malaysia)

Author keywords

Chronic obstructive pulmonary disease; Clinical outcomes; Clinical pathway; Length of stay

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PATHWAY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY;

AGED; CRITICAL PATHWAYS; DISEASE MANAGEMENT; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALAYSIA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862525130     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-27     Document Type: Article

References (22)

1. Ministry of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Thoracic Society Management of Chronic Obstructive Pulmonary disease. Clinical Practice Guidelines 2009, 2, MOH/P/PAK/197.09(GU), Ministry of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Thoracic Society.
2. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care 2009, 54(8):1040-1049.
3. Mortaz E, Lazar Z, Koenderman L, et al. Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Respir Res 2009, 10:47. 10.1186/1465-9921-10-47, 2701931, 19515231.
4. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalized patients with COPD. Eur Respir J 2005, 26(2):234-241. 10.1183/09031936.05.00024804, 16055870.
5. Lindenauer PK, Pekow P, Gao S, et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2006, 144(12):894-903.
6. Azarisman SMS, Hadzri HM, Fauzi RA, et al. Compliance to national guidelines on the management of chronic obstructive pulmonary disease in Malaysia: a single centre experience. Singapore Med J 2008, 49(11):886-896.
7. Last assessed on 27.12.2011., http://www.e-p-a.org/index2.html
8. Smith BJ, Cheok F, Ruffin RE. Impact on readmission rates and mortality of COPD disease inpatient management guidelines. Chron Respir 2004, 1(1):17-28.
9. Santamaria N, Conners AM, Osteraas J, et al. A prospective cohort study of the effectiveness of clinical pathways for the in-patient management of acute exacerbation of chronic obstructive pulmonary disease (COPD). Collegian 2004, 11(1):12-16.
10. Farley K. The COPD critical pathway: a case study in progress. Qual Manage Health Care 1995, 3:43-54.
11. Rave KF, Hurd S, Anzueto A, Barnes PJ, et al. Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med 2007, 176:532-555. 10.1164/rccm.200703-456SO, 17507545.
12. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-555. 10.1164/rccm.200703-456SO, 17507545.
13. Bellamy D. The NICE COPD Guidelines 2004-what are the messages for primary care?. Prim Care Respir J 2004, 13(2):84-88. 10.1016/j.pcrj.2004.03.001, 16701647.
14. Rampal L, Rampal S, Khor GL, et al. A national study on the prevalence of obesity among 16,127 Malaysians. Asia Pac J Clin Nutr 2007, 16(3):561-566.
15. Ministry of Health Malaysia, Academy of Health Malaysia, Academy of Medicine of Malaysia Ministry of Health Malaysia, Academy of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Association for the study of Obesity Malaysian Endocrine & Metabolic Society. Clinical Practice Guidelines on Management of Obesity 2004, Ministry of Health Malaysia, Academy of Health Malaysia, Academy of Medicine of Malaysia Ministry of Health Malaysia, Academy of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Association for the study of Obesity.
16. Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008, 32(4):962-969. 10.1183/09031936.00012408, 18579551.
17. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997, 10(12):2794-2800. 10.1183/09031936.97.10122794, 9493663.
18. Celis G, Lodewijchx C, Schoonis A, et al. Clinical pathway for acute COPD exacerbations reduces hospital stay and readmission. Website:[http://www.bvpv-sbip.be/pdf%20bestanden/ers2006_geert.pdf].Last assessed on 27.12.2011.
19. Bailey R, Weingarten S, Lewis M, et al. Impact of clinical pathways and practice guidelines on the management of acute exacerbations of bronchial asthma. Chest 1998, 113(1):28-33. 10.1378/chest.113.1.28, 9440564.
20. Estrada CA, Unterborn JA, Price J, et al. Judging the effectiveness of clinical pathways for pneumonia: the role of risk adjustment. EffClin Pract 2000, 3(5):221-228.
21. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000, 283(6):749-755. 10.1001/jama.283.6.749, 10683053.
22. Mushlin AI, Black ER, Connolly CA, et al. The necessary length of hospital stay for chronic pulmonary disease. JAMA 1991, 266(1):80-83. 10.1001/jama.1991.03470010084035, 1904506.